Relay Therapeutics, Inc. (CIK: 0001812364) EDGAR, Information, Filings... CompaniesBIO.Com

Relay Therapeutics, Inc.

Mailing address
399 BINNEY STREET, 2ND FLOOR, CAMBRIDGE, Delaware, 02139
Phone
617-370-8837
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Relay Therapeutics, Inc. (CIK: 0001812364) is an American company incorporated in the state of Massachusetts. Head office is located at 399 BINNEY STREET, 2ND FLOOR, CAMBRIDGE, Massachusetts, 02139. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Relay Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Rahmer Peter	0001959229	Dec-31-2022	officer: See remarks
Kathiresan Sekar	0001864112	Jul-25-2022	director
Porter Andy	0001899340	Dec-17-2021	officer: See Remarks
SHAW DAVID E	0001023870	Jul-15-2020	10 percent owner
HILL LINDA A	0001130483	Jul-15-2020	director
LEVIN MARK J	0001180428	Jul-15-2020	10 percent owner
INGRAM DOUGLAS S	0001190644	Jul-15-2020	director
TEPPER ROBERT I	0001192595	Jul-15-2020	10 percent owner
STARR KEVIN P	0001192603	Jul-15-2020	10 percent owner
Borisy Alexis	0001319446	Jul-15-2020	director
Nishar Dipchand	0001519500	Jul-15-2020	director
Shawver Laura	0001551891	Jul-15-2020	director
Third Rock Ventures III, L.P.	0001569705	Jul-15-2020	10 percent owner
Adams Brian	0001636994	Jul-15-2020	officer: General Counsel
TRV GP III, LLC	0001637299	Jul-15-2020	10 percent owner
Third Rock Ventures GP III, L.P.	0001637300	Jul-15-2020	10 percent owner
TRV GP IV, LLC	0001688325	Jul-15-2020	10 percent owner
Third Rock Ventures GP IV, L.P.	0001688326	Jul-15-2020	10 percent owner
Third Rock Ventures IV, L.P.	0001688327	Jul-15-2020	10 percent owner
Bergstrom Donald A	0001709772	Jul-15-2020	officer: See Remarks
Alexandria Venture Investments, LLC	0001722024	Jul-15-2020	10 percent owner
SB INVESTMENT ADVISERS (UK) LTD	0001731509	Jul-15-2020	10 percent owner
SOFTBANK VISION FUND (AIV M2) L.P.	0001805808	Jul-15-2020	10 percent owner
Murcko Mark	0001816130	Jul-15-2020	director
Patel Sanjiv	0001816210	Jul-15-2020	director, officer: President and CEO
Rubin Jami	0001816484	Jul-15-2020	director
Picularium, LLC	0001817110	Jul-15-2020	10 percent owner
SVF Pauling (Cayman) Ltd	0001817592	Jul-15-2020	10 percent owner
Catinazzo Thomas	0001818261	Jul-15-2020	officer: Vice President, Finance

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Relay Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001193125-26-107312 (34 Act) Size: KB	Mar-16-2026	001-39385 26754596
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-102270 ( Act) Size: 0 KB	Mar-11-2026
8-K	Document	Current report filing Acc-no: 0001193125-26-102178 (34 Act) Size: KB	Mar-11-2026	001-39385 26743527
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-26-002370 (33 Act) Size: 0 KB	Mar-09-2026	001-39385 26735593
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-26-076900 (33 Act) Size: KB	Feb-26-2026	333-293799 26689461
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001193125-26-076739 (34 Act) Size: KB	Feb-26-2026	001-39385 26688331
8-K	Document	Current report filing Acc-no: 0001193125-26-076617 (34 Act) Size: KB	Feb-26-2026	001-39385 26688082
SCHEDULE 13G/A	Document	Acc-no: 0000919574-26-001221 (34 Act) Size: KB	Feb-17-2026	005-92097 26642877
SCHEDULE 13G/A	Document	Acc-no: 0000919574-26-001220 (34 Act) Size: KB	Feb-17-2026	005-92097 26642822
8-K	Document	Current report filing Acc-no: 0001193125-26-034422 (34 Act) Size: KB	Feb-03-2026	001-39385 26590137
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-029415 ( Act) Size: 0 KB	Jan-29-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-029412 ( Act) Size: 0 KB	Jan-29-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-029403 ( Act) Size: 0 KB	Jan-29-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-014111 ( Act) Size: 0 KB	Jan-15-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-014110 ( Act) Size: 0 KB	Jan-15-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-014109 ( Act) Size: 0 KB	Jan-15-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-014106 ( Act) Size: 0 KB	Jan-15-2026
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-26-006328 ( Act) Size: 0 KB	Jan-07-2026
SCHEDULE 13G/A	Document	Acc-no: 0001831942-25-000024 (34 Act) Size: KB	Nov-14-2025	005-92097 251487098
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-269790 ( Act) Size: 0 KB	Nov-06-2025

Recent 20 filings. View all Relay Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Relay Therapeutics, Inc. overview
Relay Therapeutics, Inc. job
Relay Therapeutics, Inc. stock
Relay Therapeutics, Inc. ownership
Relay Therapeutics, Inc. CEO
Relay Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.